Drug safety
The safety of Fiterman Pharma drugs is continuously monitored by our Farmacovigilance department.
Within our farmacovigilance system, any information about eventual adverse events linked with Fiterman Pharma drugs is collected, evaluated and reported to regulatory authorities, and measures are taken to minimize the risk of administration.
To report on a suspected adverse reaction to any Fiterman Pharma drug, you can contact:
- medical representative in your area
- the qualified person in our farmacovigilance department
Fax: +40 232 252 800
Mobile: +40 752 226 776
E-mail: farmacovigilenta@fitermanpharma.ro
Within our farmacovigilance system, any information about eventual adverse events linked with Fiterman Pharma drugs is collected, evaluated and reported to regulatory authorities, and measures are taken to minimize the risk of administration.
To report on a suspected adverse reaction to any Fiterman Pharma drug, you can contact:
- medical representative in your area
- the qualified person in our farmacovigilance department
Fax: +40 232 252 800
Mobile: +40 752 226 776
E-mail: farmacovigilenta@fitermanpharma.ro
